PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19037088-6 2009 We found that the treatment of COX2-overexpressing HT29 human colon cancer cells with fisetin (30-120 microM) resulted in induction of apoptosis, downregulation of COX2 protein expression without affecting COX1 and inhibited the secretion of prostaglandin E2. fisetin 86-93 prostaglandin-endoperoxide synthase 2 Homo sapiens 31-35 34864006-0 2022 Fisetin suppresses cigarette smoke extract-induced epithelial to mesenchymal transition of airway epithelial cells through regulating COX-2/MMPs/beta-catenin pathway. fisetin 0-7 prostaglandin-endoperoxide synthase 2 Homo sapiens 134-139 34864006-4 2022 Further, fisetin, a bioflavonoid, exhibits antioxidant and anti-inflammatory properties, but its effect in modulating COX-2-mediated inflammation and downstream sequelae remains unexplored. fisetin 9-16 prostaglandin-endoperoxide synthase 2 Homo sapiens 118-123 33616827-8 2021 Fisetin treatment alleviated cell injury and suppressed the inflammatory cytokines (interleukin-1 (IL-1), tumor necrosis factor- alpha (TNF-alpha), inducible nitric oxide synthase (iNOS), interleukin-1beta (IL-1beta), cyclooxygenase-2 (COX-2), interleukin-16 (IL-6), and prostaglandin E2 (PGE2)) and antioxidant parameters in a dose-dependent manner. fisetin 0-7 prostaglandin-endoperoxide synthase 2 Homo sapiens 218-234 33616827-8 2021 Fisetin treatment alleviated cell injury and suppressed the inflammatory cytokines (interleukin-1 (IL-1), tumor necrosis factor- alpha (TNF-alpha), inducible nitric oxide synthase (iNOS), interleukin-1beta (IL-1beta), cyclooxygenase-2 (COX-2), interleukin-16 (IL-6), and prostaglandin E2 (PGE2)) and antioxidant parameters in a dose-dependent manner. fisetin 0-7 prostaglandin-endoperoxide synthase 2 Homo sapiens 236-241 33616827-10 2021 Fisetin significantly (P < 0.001) suppressed the neurological parameters and inflammatory cytokines such as IL-1, TNF-alpha, iNOS, IL-1beta, COX-2, IL-6, PGE2, and oxidative markers in a dose-dependent manner. fisetin 0-7 prostaglandin-endoperoxide synthase 2 Homo sapiens 141-146 25263652-6 2014 The data indicate that fisetin inhibits MAPK activation and COX-2 expression without affecting cell viability. fisetin 23-30 prostaglandin-endoperoxide synthase 2 Homo sapiens 60-65 25882230-4 2015 The results revealed that 5-25 muM fisetin inhibits cyclooxygenase-2 (COX-2) and matrix metalloproteinase (MMP)-1, MMP-3, MMP-9 expression induced by ultraviolet B (UVB) irradiation in human skin fibroblasts. fisetin 35-42 prostaglandin-endoperoxide synthase 2 Homo sapiens 52-68 25882230-4 2015 The results revealed that 5-25 muM fisetin inhibits cyclooxygenase-2 (COX-2) and matrix metalloproteinase (MMP)-1, MMP-3, MMP-9 expression induced by ultraviolet B (UVB) irradiation in human skin fibroblasts. fisetin 35-42 prostaglandin-endoperoxide synthase 2 Homo sapiens 70-75 19037088-6 2009 We found that the treatment of COX2-overexpressing HT29 human colon cancer cells with fisetin (30-120 microM) resulted in induction of apoptosis, downregulation of COX2 protein expression without affecting COX1 and inhibited the secretion of prostaglandin E2. fisetin 86-93 prostaglandin-endoperoxide synthase 2 Homo sapiens 164-168